U.S. Markets open in 40 hrs, 20 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,318.16 | -14.28 | -0.14% |
| NASDAQ | 2,146.04 | -10.78 | -0.50% |
| S&P 500 | 1,091.38 | -3.52 | -0.32% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 38.54 03:59 PM EST | |
|---|---|---|
| Day High | 39.15 09:55 AM EST |
|
| Range | 0.61 |
| Volume | 1.59 M | |
|---|---|---|
| 30-Day Avg Vol | 2.82 M |
|
| Difference | -43.77% |
| Market Cap | 6.98 B | |
|---|---|---|
| Mkt Cap Chg | -68.85 M |
| Shares Out | 181.18 M | |
|---|---|---|
| % Shrs Traded | 0.88% | |
| 1yr EPS Est | -3.307 |
| 52-Wk Low | 19.87 | |
|---|---|---|
| 52-Wk High | 41.75 |
|
| Range | 21.88 |
| Prev Close | 38.92 11/19/09 | |
|---|---|---|
| Today's Open | 38.70 | |
| Change | -0.57% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 18.45 M |
| Revenue (LFY) | 175.50 M | |
|---|---|---|
| Earnings (LFY) | -459.85 M | |
| Earnings (MRQ) | -149.56 M | |
| Next Earn Est | -0.851 | |
| Next Earnings | 02/08/2010 |
|
| EPS (TTM) | -3.82 | |
| 1yr EPS Growth | 13.66% |
| P/E Ratio (TTM) | — | |
|---|---|---|
| P/E Ratio (Fwd) | -11.00 | |
| PEG Ratio | -1.10 | |
| Return on Equity | -180.61 | |
| Beta | 0.57 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
Vertex Pharmaceuticals represents the convergence of drug discovery technologies. The biotechnology company uses an integrated, multidisciplinary approach -- employing biophysics, computer-based modeling, ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | -0.851 2/8/10 | — — |
—
—
|
| Last Quarter | -0.817 9/30/09 | -0.84 9/30/09 |
-0.023
Missed
|
| 2 Quarters Ago | -0.836 6/30/09 | -0.99 6/30/09 |
-0.154
Missed
|
| Quarterly - 09/30/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 24.96 M | 175.50 M |
| Gross Profit | 14.43 M | 127.62 M |
| Operating Income | -147.46 M | -458.38 M |
| Net Income | -149.56 M | -459.85 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts